Comparison of starting antiemetic treatment 24 hours before or concurrently with cytotoxic chemotherapy.
作者信息
Williams C J, Davies C, Raval M, Middleton J, Luken J, Stone B
机构信息
CRC Medical Oncology Unit, Southampton General Hospital.
出版信息
BMJ. 1989 Feb 18;298(6671):430-1. doi: 10.1136/bmj.298.6671.430.
Abstract
摘要
相似文献
1
Comparison of starting antiemetic treatment 24 hours before or concurrently with cytotoxic chemotherapy.在细胞毒性化疗前24小时或同时开始使用止吐治疗的比较。
BMJ. 1989 Feb 18;298(6671):430-1. doi: 10.1136/bmj.298.6671.430.
2
3
The influence of dexamethasone in the decrease of chemotherapy-induced nausea and vomiting.地塞米松在减轻化疗引起的恶心和呕吐方面的影响。
J BUON. 2007 Apr-Jun;12(2):245-52.
4
Aprepitant plus palonosetron and dexamethasone for prevention of chemotherapy-induced nausea and vomiting in patients receiving multiple-day cisplatin chemotherapy.阿瑞匹坦联合帕洛诺司琼和地塞米松预防接受多日顺铂化疗的患者化疗引起的恶心和呕吐。
Intern Med J. 2013 Jan;43(1):73-6. doi: 10.1111/j.1445-5994.2011.02637.x.
5
Infusion of palonosetron plus dexamethasone for the prevention of chemotherapy-induced nausea and vomiting.输注帕洛诺司琼加地塞米松预防化疗引起的恶心和呕吐。
J Support Oncol. 2006 Oct;4(9):467-71.
6
Comparison of antiemetic efficacy between single and repeat treatment with dexamethasone in patients receiving carboplatin-based combination chemotherapy.接受以卡铂为基础的联合化疗的患者中，地塞米松单次与重复治疗的止吐疗效比较。
Methods Find Exp Clin Pharmacol. 2010 Sep;32(7):499-505. doi: 10.1358/mf.2010.32.7.1501438.
7
Risk Model-Guided Antiemetic Prophylaxis vs Physician's Choice in Patients Receiving Chemotherapy for Early-Stage Breast Cancer: A Randomized Clinical Trial.风险模型指导的止吐预防与接受早期乳腺癌化疗患者的医生选择：一项随机临床试验。
JAMA Oncol. 2016 Feb;2(2):225-31. doi: 10.1001/jamaoncol.2015.3730.
8
Efficacy and safety of rolapitant for prevention of chemotherapy-induced nausea and vomiting over multiple cycles of moderately or highly emetogenic chemotherapy.罗拉匹坦在多周期中、高度致吐性化疗中预防化疗引起的恶心和呕吐的疗效与安全性。
Eur J Cancer. 2016 Apr;57:23-30. doi: 10.1016/j.ejca.2015.12.023. Epub 2016 Feb 4.
9
Efficacy of ondansentron treatment for acute emesis with different dosing schedules 8 vs 32 mg. A randomized study.不同给药方案（8毫克与32毫克）的昂丹司琼治疗急性呕吐的疗效：一项随机研究。
J Exp Clin Cancer Res. 2001 Mar;20(1):29-34.
10
[Efficacy of ondansetron in acute and delayed cisplatin-induced nausea and vomiting].昂丹司琼对顺铂所致急性和迟发性恶心呕吐的疗效
Bull Cancer. 1996 Feb;83(2):147-53.
引用本文的文献
1
Pharmacological Agents Affecting Emesis : A Review (Part II).影响呕吐的药物制剂：综述（第二部分）
Drugs. 1992 Apr;43(4):443-463. doi: 10.2165/00003495-199243040-00003.
2
Prolongation of the antiemetic action of P6 acupuncture by acupressure in patients having cancer chemotherapy.穴位按压延长癌症化疗患者P6针刺止吐作用的研究
J R Soc Med. 1990 Jun;83(6):360-2. doi: 10.1177/014107689008300608.
3
Adverse effects of cancer chemotherapy. An overview of techniques for avoidance/minimisation.
Drug Saf. 1992 Sep-Oct;7(5):316-22. doi: 10.2165/00002018-199207050-00002.
本文引用的文献
1
Emesis as a critical problem in chemotherapy.呕吐作为化疗中的一个关键问题。
N Engl J Med. 1981 Oct 15;305(16):948-9. doi: 10.1056/NEJM198110153051609.
2
On the receiving end--patient perception of the side-effects of cancer chemotherapy.在接受端——患者对癌症化疗副作用的认知
Eur J Cancer Clin Oncol. 1983 Feb;19(2):203-8. doi: 10.1016/0277-5379(83)90418-2.
3
Calculating confidence intervals for some non-parametric analyses.计算某些非参数分析的置信区间。
Br Med J (Clin Res Ed). 1988 May 21;296(6634):1454-6. doi: 10.1136/bmj.296.6634.1454.
Zotero 插件